SEC Form 4 · accession 0001209191-17-011203
IRONWOOD PHARMACEUTICALS INC · IRWD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Halley E Gilbert
Officer — Chief Legal Officer
Period of report
Feb 14, 2017
Accepted (ET)
Feb 15, 2017 · 6:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001446847
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class B Common Stock | Feb 14, 2017 | M | 37,385 | $3.76 | A | 37,385 | D | |
| Class B Common Stock | Feb 14, 2017 | S | 37,385 | $16.75 | D | 0 | D | |
| Class A Common StockF2 | holding | — | — | — | 65,846 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $3.76 | Feb 14, 2017 | M | 37,385 | D | — | Jan 31, 2018 | Class B Common Stock | 37,385 | 0 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. In order to effect the sale, these shares of Class B Common Stock were converted into shares of Class A Common Stock in accordance with the issuer's certificate of incorporation.
- F2The reporting person acquired 379 shares of Class A Common Stock under the issuer's employee stock purchase plan on December 31, 2016.
- F3The option vested as to 25% of the shares of Class B Common Stock on the first anniversary of February 1, 2008, and 1/48th of the shares of Class B Common Stock vested each month thereafter for the next 36 months. The option was fully vested as of February 1, 2012.
Remarks
Exhibit 24: Power of Attorney